Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.52 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.52 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28949324 | 0.94 | CYP3A4 (0.47) | CYP3A4TRPA1GABRA1GABRB2ALDH1A1 | |
| SCHEMBL295649 | 0.89 | CYP3A4 (0.50) | CYP3A4TRPA1GABRA1GABRB2ALDH1A1 | |
| SCHEMBL5577120 | 0.86 | CYP3A4 (0.48) | CYP3A4TRPA1GABRA1GABRB2ALDH1A1 | |
| SCHEMBL29930513 | 0.85 | CYP3A4 (0.52) | CYP3A4TRPA1GABRA1GABRB2ALDH1A1 | |
| SCHEMBL110656 | 0.85 | CYP3A4 (0.52) | CYP3A4TRPA1GABRA1GABRB2ALDH1A1 | |
| SCHEMBL291584 | 0.85 | CYP3A4 (0.57) | CYP3A4TRPA1GABRA1GABRB2ALDH1A1 | |
| SCHEMBL10316539 | 0.82 | CYP3A4 (0.47) | CYP3A4TRPA1GABRA1GABRB2ALDH1A1 | |
| SCHEMBL10316854 | 0.82 | CYP3A4 (0.47) | CYP3A4TRPA1GABRA1GABRB2ALDH1A1 | |
| SCHEMBL20145 | 0.81 | CYP3A4 (0.63) | CYP3A4TRPA1GABRA1GABRB2ALDH1A1 | |
| SCHEMBL30520271 | 0.81 | CYP3A4 (0.63) | CYP3A4TRPA1GABRA1GABRB2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 634 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4598976-A1 | A TWO-COMPONENT POLYURETHANE FOR POLYCARBONATE BONDING | ARKEMA FRANCE (FR) | 2025-08-13 | — | — | EP | claimed |
| CN-119998349-A | Two-component polyurethane for polycarbonate bonding | 阿科玛法国 | 2025-05-13 | — | — | CN | claimed |
| WO-2024074344-A1 | A TWO-COMPONENT POLYURETHANE FOR POLYCARBONATE BONDING | ARKEMA FRANCE (FR) | 2024-04-11 | — | — | WO | claimed |
| EP-4349878-A1 | A TWO-COMPONENT POLYURETHANE FOR POLYCARBONATE BONDING | ARKEMA FRANCE (FR) | 2024-04-10 | — | — | EP | claimed |
| US-20170361421-A1 | HIGH REMOVAL RATE CHEMICAL MECHANICAL POLISHING PADS AND METHODS OF MAKING | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2017-12-21 | — | — | US | claimed |
| EP-2410971-B1 | RADIATION-CURING, HIGHLY FUNCTIONAL POLYURETHANE (METH)ACRYLATE | BASF SE (DE) | 2017-08-16 | — | — | EP | claimed |
| US-9200108-B2 | Radiation-curing, highly functional polyurethane (meth)acrylate | BASF SE (DE) | 2015-12-01 | — | — | US | claimed |
| CN-104169320-A | Wood adhesive formulation | HUNTSMAN INT LLC | 2014-11-26 | — | — | CN | claimed |
| CN-104039855-A | Wood Adhesive Formulation | HUNTSMAN INT LLC | 2014-09-10 | — | — | CN | claimed |
| CN-102015780-B | Substrates and articles coated with aqueous 2K coating compositions | PPG IND OHIO INC | 2014-07-30 | — | — | CN | claimed |
| US-6416686-B2 | Polyisocyanates | BASF AKTIENGESELLSCHAFT (DE) | 2002-07-09 | — | — | US | claimed |
| US-6376637-B1 | USING BRANCHED POLYISOCYANATES | BASF CORPORATION | 2002-04-23 | — | — | US | claimed |
| US-20020007036-A1 | High-functionality polyisocyanates | BASF AKTIENGESELLSCHAFT (DE) | 2002-01-17 | — | — | US | claimed |
| US-20010025096-A1 | Polyisocyanates | BASF AKTIENGESELLSCHAFT (DE) | 2001-09-27 | — | — | US | claimed |
| EP-1134247-A2 | Highfunctionality polyisocyanates | BASF AKTIENGESELLSCHAFT (DE) | 2001-09-19 | — | — | EP | claimed |
| EP-1134246-A2 | Polyisocyanate | BASF AKTIENGESELLSCHAFT (DE) | 2001-09-19 | — | — | EP | claimed |
| EP-1026185-A1 | Dendrimers and highly branched polyurethanes | BASF AKTIENGESELLSCHAFT (DE) | 2000-08-09 | — | — | EP | claimed |
| EP-0613913-A1 | Crosslinking agent for polymer adhesives on the basis of reaction products of 2,4,6-triisocyanato-toluene and polyols | BAYER AG (DE) | 1994-09-07 | — | — | EP | claimed |
| EP-0072915-B1 | PROCESS FOR PREPARING 2,4,6-TRIISOCYANATOTOLUENE | BASF Aktiengesellschaft (DE) | 1986-05-21 | — | — | EP | claimed |
| US-4456493-A | ALKYNEDIOL AND FORMALDEHYDE PREPOLYMER WITH POLYISOCYANATE | THIOKOL CORPORATION (US) | 1984-06-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020007036-A1 | High-functionality polyisocyanates | PCBP1, C9, CYP1B1 | CYP3A4 72/4885TRPA1 2513/4885GABRA1 1146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.